Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Multiple Myeloma Treatment Is Associated with Enhanced Platelet Reactivity

Jonathan Gibbins, BSc, PhD, Rekha Rana, Dalia Khan, Susie Shapiro, MD, Henri Grech, Karthik Ramasamy, MD PhD

Blood (2018) 132 (Supplement 1): 3300.

https://doi.org/10.1182/blood-2018-99-116006

Published: 2018

Journal Articles

Defining Risk of MGUS and AMM Progression to Myeloma By Ig Heavy-Chain FISH

Erming Tian, PhD, Pingping Qu, PhD, Caleb K Stein, MS, Gareth J Morgan, MD PhD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc

Blood (2014) 124 (21): 3408.

https://doi.org/10.1182/blood.V124.21.3408.3408

Published: 2014

Journal Articles

Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans

Arianna Calcinotto, Maurilio Ponzoni, Roberto Ria, Matteo Grioni, Elena Cattaneo, Isabella Villa, Maria Teresa Sabrina Bertilaccio, Marta Chesi, PhD, Alessandro Rubinacci, Giovanni Tonon, MDPhD, Peter Leif Bergsagel, MD PhD, Angelo Vacca, MD PhD, Matteo Bellone, MD

Blood (2014) 124 (21): 5678.

https://doi.org/10.1182/blood.V124.21.5678.5678

Published: 2014

Journal Articles

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)

Madhav V. Dhodapkar, Rachael Sexton, Sarah Waheed, Saad Usmani, Xenofon Papanikolaou, Bijay Nair, Nathan Petty, John D. Shaughnessy, Jr, Antje Hoering, John Crowley, Robert Z. Orlowski, Bart Barlogie

Blood (2014) 123 (1): 78–85.

https://doi.org/10.1182/blood-2013-07-515239

Published: 2014

Includes: Supplemental data

Journal Articles

Validation of Immuno-Magnetic Chromatography As a Novel Method for the in Situ enrichment of Plasma Cells in Bone Marrow.

Eric Crawford, PhD, ABMG, Victoria Golembiewski-Ruiz, MBA, Mingya Liu, MS, Robert D MacPhee, Jr., PhD

Blood (2012) 120 (21): 2930.

https://doi.org/10.1182/blood.V120.21.2930.2930

Published: 2012

Journal Articles

Bone Marrow Biopsy May Be Required During the Initial Evaluation of Individuals with Asymptomatic Monoclonal Gammopathy

Meletios Athanasios Dimopoulos, MD, Evangelos Terpos, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Maria Gavriatopoulou, Dimitrios Christoulas, Maria Roussou, Efstathios Kastritis

Blood (2011) 118 (21): 5067.

https://doi.org/10.1182/blood.V118.21.5067.5067

Published: 2011

Journal Articles

Mean Corpuscular Volume as An Early Predictor of Malignant Evolution of Monoclonal Gammopathy of Undetermined Significance

Mustapha A. Khalife, MD, Philip Kuriakose, MD, Marwa Hammoud

Blood (2010) 116 (21): 1925.

https://doi.org/10.1182/blood.V116.21.1925.1925

Published: 2010

Journal Articles

Bortezomib for ITP: First Report of Successful Treatment of Refractory ITP In a Patient with Otherwise Asymptomatic Monoclonal Gammopathy

Aleksandr Lazaryan, MD, MPH, PhD, Alan E. Lichtin, MD, Keith R McCrae, M.D., Janice Reed, RN, Robert Dean, MD, Claudiu Cotta, MD, Frederic J. Reu, MD

Blood (2010) 116 (21): 4667.

https://doi.org/10.1182/blood.V116.21.4667.4667

Published: 2010

Journal Articles

Phenotypic Analysis of Plasma Cells in Monoclonal Gammopathy and Multiple Myeloma Subjects.

Lucie Kovarova, Ivana Buresova, Ludek Pour, M.D., Renata Suska, Zdenek Adam, M.D., Marta Krejci, M.D., PhD., Jiri Vorlicek, M.D., Miroslav Penka, M.D., Roman Hajek, M.D.

Blood (2007) 110 (11): 4755.

https://doi.org/10.1182/blood.V110.11.4755.4755

Published: 2007

Journal Articles

A Gene Expression Signature of Benign Monoclonal Gammopathy Evident in Multiple Myeloma Is Linked to Good Prognosis.

Fenghuang Zhan, Bart Barlogie, Varant Arzoumanian, Yongsheng Huang, Klaus Hollmig, Mauricio Pineda-Roman, Guido Tricot, Frits van Rhee, Maurizio Zangari, Madhav Dhodapkar, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3393.

https://doi.org/10.1182/blood.V108.11.3393.3393

Published: 2006

Journal Articles

Interphase FISH in Multiple Myeloma.

Jacob Haaber, Anne G. Sørensen, Anne Nibe, Ole Nielsen, Niels Abildgaard, Torben Plesner, Gitte B. Kerndrup

Blood (2006) 108 (11): 5023.

https://doi.org/10.1182/blood.V108.11.5023.5023

Published: 2006

NARROW

Multiple Myeloma Treatment Is Associated with Enhanced Platelet Reactivity

Defining Risk of MGUS and AMM Progression to Myeloma By Ig Heavy-Chain FISH

Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)

Validation of Immuno-Magnetic Chromatography As a Novel Method for the in Situ enrichment of Plasma Cells in Bone Marrow.

Bone Marrow Biopsy May Be Required During the Initial Evaluation of Individuals with Asymptomatic Monoclonal Gammopathy

Mean Corpuscular Volume as An Early Predictor of Malignant Evolution of Monoclonal Gammopathy of Undetermined Significance

Bortezomib for ITP: First Report of Successful Treatment of Refractory ITP In a Patient with Otherwise Asymptomatic Monoclonal Gammopathy

Phenotypic Analysis of Plasma Cells in Monoclonal Gammopathy and Multiple Myeloma Subjects.

A Gene Expression Signature of Benign Monoclonal Gammopathy Evident in Multiple Myeloma Is Linked to Good Prognosis.

Interphase FISH in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only